| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.626 | 0.016 | 0.626 | Antibacterial | 0.3 0.135 DBMET01968 0.449 0.057 DBMET01969 0.449 0.057 DBMET01970 0.214 0.213 DBMET01971 | ||
| 0.43 | 0.009 | 0.516 | Platelet adhesion inhibitor | 0.411 0.01 DBMET01965 0.202 0.07 DBMET01966 0.516 0.005 DBMET01968 0.143 0.114 DBMET01972 0.171 0.088 DBMET01967 0.256 0.047 DBMET01969 0.256 0.047 DBMET01970 0.264 0.045 DBMET01971 | DBMET01968 | |
| 0.344 | 0.008 | 0.344 | Cell wall synthesis inhibitor | 0.121 0.097 DBMET01966 | ||
| 0.299 | 0.049 | 0.505 | HERG channel blocker | 0.505 0.015 DBMET01965 0.383 0.031 DBMET01966 0.303 0.048 DBMET01968 0.268 0.059 DBMET01972 0.212 0.083 DBMET01967 0.167 0.113 DBMET01969 0.167 0.113 DBMET01970 0.407 0.027 DBMET01971 | DBMET01965 | |
| 0.244 | 0.035 | 0.312 | Thrombolytic | 0.299 0.024 DBMET01965 0.163 0.072 DBMET01966 0.312 0.022 DBMET01968 0.164 0.071 DBMET01967 0.161 0.074 DBMET01969 0.161 0.074 DBMET01970 0.175 0.065 DBMET01971 | DBMET01968 | |
| 0.258 | 0.064 | 0.464 | Potassium channel (Voltage-sensitive) blocker | 0.464 0.018 DBMET01965 0.349 0.037 DBMET01966 0.304 0.048 DBMET01968 0.253 0.066 DBMET01972 0.196 0.098 DBMET01967 0.164 0.126 DBMET01969 0.164 0.126 DBMET01970 0.395 0.028 DBMET01971 | DBMET01965 | |
| 0.172 | 0.044 | 0.225 | CF transmembrane conductance regulator agonist | 0.209 0.017 DBMET01965 0.218 0.013 DBMET01966 0.206 0.019 DBMET01968 0.225 0.011 DBMET01972 0.183 0.033 DBMET01967 0.199 0.022 DBMET01969 0.199 0.022 DBMET01970 0.211 0.016 DBMET01971 | DBMET01972 | |
| 0.19 | 0.099 | 0.316 | Potassium channel blocker | 0.308 0.044 DBMET01965 0.216 0.083 DBMET01966 0.235 0.074 DBMET01968 0.254 0.064 DBMET01972 0.316 0.041 DBMET01971 | DBMET01971 | |
| 0.062 | 0.015 | 0.196 | Cholesterol esterase inhibitor | 0.095 0.005 DBMET01965 0.114 0.004 DBMET01966 0.151 0.004 DBMET01968 0.085 0.005 DBMET01972 0.095 0.005 DBMET01967 0.151 0.004 DBMET01969 0.151 0.004 DBMET01970 0.196 0.003 DBMET01971 | DBMET01971 | |
| 0.173 | 0.129 | 0.173 | Vasodilator | |||
| 0.062 | 0.025 | 0.062 | Factor IXa inhibitor | 0.046 0.045 DBMET01967 | ||
| 0.118 | 0.085 | 0.118 | Antibacterial (Helicobacter pylori) | |||
| 0.05 | 0.018 | 0.095 | G protein-coupled receptor agonist | 0.095 0.006 DBMET01965 0.047 0.019 DBMET01966 0.077 0.009 DBMET01968 0.057 0.014 DBMET01972 0.041 0.024 DBMET01967 0.046 0.02 DBMET01969 0.046 0.02 DBMET01970 0.083 0.008 DBMET01971 | DBMET01965 | |
| 0.078 | 0.051 | 0.09 | MAP kinase 7 inhibitor | 0.087 0.024 DBMET01965 0.086 0.028 DBMET01966 0.087 0.024 DBMET01968 0.082 0.037 DBMET01972 0.087 0.025 DBMET01967 0.084 0.032 DBMET01969 0.084 0.032 DBMET01970 0.09 0.019 DBMET01971 | DBMET01971 | |
| 0.06 | 0.048 | 0.06 | Nitric oxide donor | |||
| 0.049 | 0.038 | 0.055 | Sodium/calcium exchanger inhibitor | 0.055 0.025 DBMET01965 0.052 0.031 DBMET01966 0.047 0.041 DBMET01968 0.051 0.032 DBMET01967 0.049 0.037 DBMET01971 | DBMET01965 | |
| 0.071 | 0.07 | 0.114 | Phosphodiesterase 3A inhibitor | 0.092 0.039 DBMET01967 0.114 0.024 DBMET01971 | DBMET01971 | |
| 0.027 | 0.027 | 0.037 | Thiazolidinedione | 0.031 0.016 DBMET01965 0.031 0.018 DBMET01966 0.034 0.012 DBMET01968 0.035 0.012 DBMET01967 0.032 0.015 DBMET01969 0.032 0.015 DBMET01970 0.037 0.01 DBMET01971 | DBMET01971 | |
| 0.105 | 0.11 | 0.314 | Lipid peroxidase inhibitor | 0.163 0.06 DBMET01965 0.214 0.036 DBMET01966 0.314 0.017 DBMET01968 0.164 0.059 DBMET01967 0.257 0.025 DBMET01969 0.257 0.025 DBMET01970 0.224 0.033 DBMET01971 | DBMET01968 | |
| 0.229 | 0.236 | 0.838 | Cyclophilin D inhibitor | 0.801 0.007 DBMET01965 0.725 0.012 DBMET01966 0.555 0.036 DBMET01968 0.537 0.04 DBMET01972 0.663 0.018 DBMET01967 0.595 0.028 DBMET01969 0.595 0.028 DBMET01970 0.838 0.005 DBMET01971 | DBMET01971 | |
| 0.049 | 0.058 | 0.096 | Glutamate (mGluR) agonist | 0.081 0.03 DBMET01968 0.061 0.044 DBMET01969 0.061 0.044 DBMET01970 0.096 0.024 DBMET01971 | DBMET01971 | |
| 0.026 | 0.038 | 0.043 | Glucose-dependent insulinotropic receptor agonist | 0.043 0.015 DBMET01965 0.035 0.023 DBMET01968 0.038 0.019 DBMET01971 | DBMET01965 | |
| 0.037 | 0.057 | 0.056 | Plasminogen activator inhibitor antagonist | 0.051 0.032 DBMET01968 0.05 0.033 DBMET01969 0.05 0.033 DBMET01970 0.056 0.027 DBMET01971 | DBMET01971 | |
| 0.03 | 0.052 | 0.049 | Acid-sensing ion channel blocker | 0.043 0.024 DBMET01965 0.041 0.027 DBMET01966 0.045 0.022 DBMET01968 0.049 0.018 DBMET01967 0.04 0.028 DBMET01969 0.04 0.028 DBMET01970 0.047 0.019 DBMET01971 | DBMET01967 | |
| 0.012 | 0.036 | 0.053 | Epoxide hydrolase 2 inhibitor | 0.053 0.005 DBMET01972 | DBMET01972 | |
| 0.19 | 0.22 | 0.679 | Antiobesity | 0.679 0.013 DBMET01965 0.504 0.036 DBMET01966 0.455 0.048 DBMET01968 0.642 0.016 DBMET01972 0.368 0.079 DBMET01967 0.467 0.045 DBMET01969 0.467 0.045 DBMET01970 0.512 0.035 DBMET01971 | DBMET01965 | |
| 0.187 | 0.221 | 0.246 | Ca(v)3.3 blocker | 0.231 0.132 DBMET01965 0.202 0.189 DBMET01966 0.224 0.144 DBMET01968 0.246 0.107 DBMET01972 0.242 0.113 DBMET01967 0.228 0.137 DBMET01971 | DBMET01972 | |
| 0.076 | 0.111 | 0.248 | Nav1.1 sodium channel blocker | 0.134 0.04 DBMET01965 0.248 0.012 DBMET01966 0.143 0.036 DBMET01968 0.147 0.034 DBMET01972 0.218 0.016 DBMET01967 0.239 0.013 DBMET01969 0.239 0.013 DBMET01970 0.157 0.03 DBMET01971 | DBMET01966 | |
| 0.147 | 0.185 | 0.542 | Hypoglycemic | 0.542 0.012 DBMET01965 0.305 0.051 DBMET01966 0.29 0.056 DBMET01968 0.189 0.124 DBMET01972 0.249 0.077 DBMET01967 0.34 0.04 DBMET01969 0.34 0.04 DBMET01970 0.405 0.027 DBMET01971 | DBMET01965 | |
| 0.016 | 0.058 | 0.069 | Factor X inhibitor | 0.064 0.017 DBMET01965 0.069 0.016 DBMET01968 0.036 0.029 DBMET01969 0.036 0.029 DBMET01970 | DBMET01968 | |
| 0.05 | 0.094 | 0.087 | Thrombin inhibitor | 0.082 0.04 DBMET01965 0.087 0.035 DBMET01968 | DBMET01968 | |
| 0.035 | 0.088 | 0.186 | NMDA 2B receptor antagonist | 0.052 0.039 DBMET01965 0.054 0.037 DBMET01966 0.178 0.007 DBMET01968 0.09 0.018 DBMET01967 0.155 0.009 DBMET01969 0.155 0.009 DBMET01970 0.186 0.006 DBMET01971 | DBMET01971 | |
| 0.031 | 0.09 | 0.091 | Diacylglycerol O-acyltransferase inhibitor | 0.091 0.01 DBMET01972 0.049 0.038 DBMET01971 | DBMET01972 | |
| 0.059 | 0.121 | 0.2 | Bronchodilator | 0.106 0.057 DBMET01966 0.196 0.019 DBMET01968 0.116 0.047 DBMET01972 0.113 0.05 DBMET01967 0.157 0.029 DBMET01969 0.157 0.029 DBMET01970 0.2 0.018 DBMET01971 | DBMET01971 | |
| 0.097 | 0.169 | 0.144 | NOS3 expression enhancer | 0.131 0.097 DBMET01966 0.131 0.096 DBMET01968 0.141 0.083 DBMET01969 0.141 0.083 DBMET01970 0.144 0.078 DBMET01971 | DBMET01971 | |
| 0.043 | 0.115 | 0.108 | Nav1.8 sodium channel blocker | 0.074 0.05 DBMET01965 0.067 0.061 DBMET01966 0.088 0.035 DBMET01968 0.108 0.025 DBMET01972 0.074 0.05 DBMET01967 0.072 0.053 DBMET01969 0.072 0.053 DBMET01970 0.099 0.028 DBMET01971 | DBMET01972 | |
| 0.021 | 0.102 | 0.065 | Acetyl-CoA carboxylase inhibitor | 0.065 0.013 DBMET01972 | DBMET01972 | |
| 0.005 | 0.09 | 0.018 | Free fatty acid receptor 1 agonist | 0.018 0.012 DBMET01971 | DBMET01971 | |
| 0.006 | 0.094 | 0.031 | Acetyl-CoA carboxylase 2 inhibitor | 0.031 0.011 DBMET01972 | DBMET01972 | |
| 0.073 | 0.17 | 0.097 | Electron transport complex I inhibitor | 0.095 0.094 DBMET01966 0.097 0.09 DBMET01969 0.097 0.09 DBMET01970 0.097 0.089 DBMET01971 | DBMET01971 | |
| 0.059 | 0.157 | 0.084 | Lanosterol 14 alpha demethylase inhibitor | 0.084 0.082 DBMET01966 | DBMET01966 | |
| 0.069 | 0.169 | 0.192 | Phosphodiesterase inhibitor | 0.192 0.037 DBMET01968 0.168 0.048 DBMET01971 | DBMET01968 | |
| 0.089 | 0.195 | 0.172 | Insulin secretagoues | 0.161 0.064 DBMET01968 0.122 0.108 DBMET01972 0.14 0.085 DBMET01967 0.166 0.059 DBMET01969 0.166 0.059 DBMET01970 0.172 0.054 DBMET01971 | DBMET01971 | |
| 0.043 | 0.155 | 0.062 | Trypsin inhibitor | 0.062 0.044 DBMET01966 0.057 0.056 DBMET01968 0.06 0.048 DBMET01969 0.06 0.048 DBMET01970 | DBMET01966 | |
| 0.017 | 0.136 | 0.049 | Phosphodiesterase 2A inhibitor | 0.049 0.035 DBMET01972 | DBMET01972 | |
| 0.031 | 0.151 | 0.082 | Phosphodiesterase 4D inhibitor | 0.082 0.046 DBMET01968 0.067 0.058 DBMET01971 | DBMET01968 | |
| 0.112 | 0.235 | 0.166 | Catenin beta inhibitor | 0.143 0.122 DBMET01965 0.157 0.091 DBMET01966 0.144 0.121 DBMET01968 0.166 0.073 DBMET01972 0.144 0.12 DBMET01967 0.149 0.109 DBMET01969 0.149 0.109 DBMET01970 0.154 0.097 DBMET01971 | DBMET01972 | |
| 0.015 | 0.142 | 0.057 | Phosphodiesterase II inhibitor | 0.057 0.036 DBMET01972 | DBMET01972 | |
| 0.046 | 0.175 | 0.063 | Calcium channel P-type blocker | 0.063 0.047 DBMET01967 | DBMET01967 | |
| 0.073 | 0.205 | 0.22 | Anticoagulant | 0.118 0.115 DBMET01965 0.22 0.047 DBMET01968 0.21 0.05 DBMET01967 0.16 0.072 DBMET01969 0.16 0.072 DBMET01970 0.127 0.103 DBMET01971 | DBMET01968 | |
| 0.01 | 0.157 | 0.142 | Melanin-concentrating hormone receptor 1 antagonist | 0.049 0.041 DBMET01968 0.142 0.007 DBMET01972 0.074 0.022 DBMET01971 | DBMET01972 | |
| 0.048 | 0.225 | 0.204 | AMP-activated protein kinase stimulant | 0.104 0.065 DBMET01965 0.145 0.032 DBMET01966 0.122 0.047 DBMET01968 0.204 0.01 DBMET01972 0.154 0.026 DBMET01967 0.141 0.034 DBMET01969 0.141 0.034 DBMET01970 0.144 0.032 DBMET01971 | DBMET01972 | |
| 0.009 | 0.196 | 0.038 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DBMET01968 0.038 0.015 DBMET01972 0.029 0.026 DBMET01969 0.029 0.026 DBMET01970 0.033 0.02 DBMET01971 | DBMET01972 | |
| 0.153 | 0.351 | 0.223 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.202 0.16 DBMET01966 0.223 0.11 DBMET01972 0.206 0.149 DBMET01967 0.196 0.177 DBMET01969 0.196 0.177 DBMET01970 0.207 0.148 DBMET01971 | DBMET01972 | |
| 0.029 | 0.239 | 0.07 | Ca(v)3.2 blocker | 0.07 0.023 DBMET01972 | DBMET01972 | |
| 0.014 | 0.24 | 0.114 | Acetylcholine M5 receptor agonist | 0.092 0.025 DBMET01968 0.061 0.053 DBMET01967 0.114 0.013 DBMET01971 | DBMET01971 | |
| 0.006 | 0.241 | 0.039 | Farnesoid X receptor agonist | 0.039 0.025 DBMET01972 0.035 0.03 DBMET01971 | DBMET01972 | |
| 0.04 | 0.275 | 0.277 | Nav1.6 sodium channel blocker | 0.145 0.06 DBMET01965 0.206 0.017 DBMET01966 0.276 0.007 DBMET01968 0.155 0.049 DBMET01967 0.277 0.007 DBMET01969 0.277 0.007 DBMET01970 0.222 0.014 DBMET01971 | DBMET01970 | |
| 0.012 | 0.251 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.007 DBMET01966 0.049 0.007 DBMET01969 0.049 0.007 DBMET01970 | DBMET01970 | |
| 0.018 | 0.26 | 0.08 | Phosphodiesterase III inhibitor | 0.08 0.035 DBMET01971 | DBMET01971 | |
| 0.008 | 0.253 | 0.106 | Phosphodiesterase 3B inhibitor | 0.106 0.01 DBMET01971 | DBMET01971 | |
| 0.015 | 0.26 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET01969 0.054 0.036 DBMET01970 | DBMET01970 | |
| 0.015 | 0.268 | 0.067 | Amidase inhibitor | 0.067 0.053 DBMET01972 | DBMET01972 | |
| 0.009 | 0.262 | 0.037 | Peroxisome proliferator-activated receptor delta antagonist | 0.037 0.017 DBMET01971 | DBMET01971 | |
| 0.021 | 0.294 | 0.081 | Acetylcholine agonist | 0.081 0.064 DBMET01968 | DBMET01968 | |
| 0.017 | 0.29 | 0.075 | Lipase inhibitor | 0.075 0.048 DBMET01971 | DBMET01971 | |
| 0.006 | 0.28 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET01966 0.037 0.005 DBMET01969 0.037 0.005 DBMET01970 | DBMET01970 | |
| 0.019 | 0.298 | 0.167 | Epoxide hydrolase inhibitor | 0.074 0.049 DBMET01968 0.167 0.009 DBMET01972 0.078 0.044 DBMET01971 | DBMET01972 | |
| 0.052 | 0.332 | 0.824 | Anticonvulsant | 0.251 0.057 DBMET01966 0.481 0.014 DBMET01968 0.379 0.024 DBMET01972 0.225 0.067 DBMET01967 0.654 0.005 DBMET01969 0.654 0.005 DBMET01970 0.824 0.004 DBMET01971 | DBMET01971 | |
| 0.06 | 0.35 | 0.158 | Polo-like kinase-3 inhibitor | 0.158 0.076 DBMET01967 0.157 0.076 DBMET01971 | DBMET01967 | |
| 0.041 | 0.357 | 0.111 | Protein kinase stimulant | 0.111 0.103 DBMET01966 | DBMET01966 | |
| 0.044 | 0.376 | 0.381 | Hypolipemic | 0.2 0.094 DBMET01966 0.3 0.049 DBMET01968 0.254 0.065 DBMET01972 0.315 0.044 DBMET01969 0.315 0.044 DBMET01970 0.381 0.029 DBMET01971 | DBMET01971 | |
| 0.011 | 0.372 | 0.122 | Phosphodiesterase IV inhibitor | 0.122 0.032 DBMET01968 0.082 0.059 DBMET01971 | DBMET01968 | |
| 0.008 | 0.37 | 0.178 | Peroxisome proliferator-activated receptor gamma agonist | 0.178 0.008 DBMET01971 | DBMET01971 | |
| 0.039 | 0.404 | 0.184 | Nav1.2 sodium channel blocker | 0.184 0.041 DBMET01966 0.147 0.058 DBMET01968 0.123 0.08 DBMET01972 0.143 0.061 DBMET01967 0.156 0.053 DBMET01969 0.156 0.053 DBMET01970 0.114 0.091 DBMET01971 | DBMET01966 | |
| 0.033 | 0.402 | 0.137 | Nav1.5 sodium channel blocker | 0.098 0.088 DBMET01965 0.137 0.036 DBMET01966 0.136 0.037 DBMET01968 0.112 0.065 DBMET01967 0.12 0.054 DBMET01969 0.12 0.054 DBMET01970 0.111 0.067 DBMET01971 | DBMET01966 | |
| 0.032 | 0.409 | 0.098 | Nav1.4 sodium channel blocker | 0.098 0.08 DBMET01966 | DBMET01966 | |
| 0.009 | 0.406 | 0.075 | Nav1.7 sodium channel blocker | 0.075 0.038 DBMET01968 0.062 0.055 DBMET01971 | DBMET01968 | |
| 0.019 | 0.423 | 0.098 | TRKA antagonist | 0.098 0.092 DBMET01972 | DBMET01972 | |
| 0.017 | 0.434 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.057 DBMET01971 | DBMET01971 | |
| 0.013 | 0.435 | 0.078 | MAP3K7 inhibitor | 0.078 0.042 DBMET01972 | DBMET01972 | |
| 0.016 | 0.44 | 0.048 | Autotaxin inhibitor | 0.048 0.045 DBMET01969 0.048 0.045 DBMET01970 | DBMET01970 | |
| 0.018 | 0.457 | 0.107 | Tyrosine-protein kinase receptor antagonist | 0.107 0.1 DBMET01972 | DBMET01972 | |
| 0.004 | 0.444 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 DBMET01971 | DBMET01971 | |
| 0.004 | 0.448 | 0.045 | Peroxisome proliferator-activated receptor alpha agonist | 0.045 0.036 DBMET01971 | DBMET01971 | |
| 0.037 | 0.504 | 0.13 | Interleukin 6 antagonist | 0.13 0.125 DBMET01966 | DBMET01966 | |
| 0.009 | 0.477 | 0.03 | Vanilloid 4 antagonist | 0.03 0.029 DBMET01968 | DBMET01968 | |
| 0.051 | 0.562 | 0.788 | Toll-Like receptor 7 agonist | 0.261 0.138 DBMET01968 0.788 0.005 DBMET01972 0.356 0.079 DBMET01971 | DBMET01972 | |
| 0.058 | 0.571 | 0.423 | Analgesic | 0.423 0.075 DBMET01968 0.253 0.18 DBMET01972 0.231 0.202 DBMET01969 0.231 0.202 DBMET01970 0.345 0.111 DBMET01971 | DBMET01968 | |
| 0.012 | 0.526 | 0.165 | Sodium channel (voltage-gated) blocker | 0.107 0.101 DBMET01966 0.165 0.045 DBMET01968 0.108 0.1 DBMET01969 0.108 0.1 DBMET01970 0.136 0.067 DBMET01971 | DBMET01968 | |
| 0.049 | 0.569 | 0.783 | Toll-Like receptor agonist | 0.259 0.14 DBMET01968 0.783 0.005 DBMET01972 0.356 0.079 DBMET01971 | DBMET01972 | |
| 0.008 | 0.535 | 0.097 | CC chemokine receptor antagonist | 0.097 0.037 DBMET01972 | DBMET01972 | |
| 0.008 | 0.555 | 0.097 | Androgen antagonist | 0.097 0.049 DBMET01972 0.08 0.066 DBMET01971 | DBMET01972 | |
| 0.028 | 0.596 | 0.123 | Aurora-C kinase inhibitor | 0.123 0.099 DBMET01972 | DBMET01972 | |
| 0.022 | 0.606 | 0.203 | DNA synthesis inhibitor | 0.194 0.132 DBMET01966 0.203 0.119 DBMET01969 0.203 0.119 DBMET01970 | DBMET01970 | |
| 0.01 | 0.602 | 0.134 | Sodium channel blocker | 0.134 0.07 DBMET01968 0.106 0.103 DBMET01971 | DBMET01968 | |
| 0.012 | 0.609 | 0.123 | Beta amyloid protein antagonist | 0.123 0.064 DBMET01965 0.115 0.072 DBMET01966 | DBMET01965 | |
| 0.021 | 0.62 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DBMET01972 | DBMET01972 | |
| 0.005 | 0.611 | 0.407 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.135 0.007 DBMET01965 0.13 0.007 DBMET01966 0.407 0.003 DBMET01967 0.049 0.03 DBMET01971 | DBMET01967 | |
| 0.014 | 0.632 | 0.197 | Insulin sensitizer | 0.197 0.076 DBMET01971 | DBMET01971 | |
| 0.005 | 0.631 | 0.058 | Mineralocorticoid receptor antagonist | 0.056 0.024 DBMET01968 0.05 0.03 DBMET01969 0.05 0.03 DBMET01970 0.058 0.021 DBMET01971 | DBMET01971 | |
| 0.032 | 0.667 | 0.171 | Superoxide dismutase inhibitor | 0.171 0.154 DBMET01972 | DBMET01972 | |
| 0.048 | 0.692 | 0.357 | Antiinflammatory | 0.31 0.206 DBMET01968 0.357 0.167 DBMET01972 | DBMET01972 | |
| 0.013 | 0.672 | 0.154 | Platelet antagonist | 0.154 0.14 DBMET01967 | DBMET01967 | |
| 0.018 | 0.685 | 0.123 | Cytokine production inhibitor | 0.123 0.086 DBMET01972 | DBMET01972 | |
| 0.014 | 0.702 | 0.081 | Chymotrypsin inhibitor | 0.081 0.053 DBMET01969 0.081 0.053 DBMET01970 | DBMET01970 | |
| 0.005 | 0.699 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET01972 0.059 0.053 DBMET01971 | DBMET01971 | |
| 0.005 | 0.71 | 0.127 | Chemokine receptor antagonist | 0.127 0.044 DBMET01972 | DBMET01972 | |
| 0.002 | 0.708 | 0.086 | CC chemokine 1 receptor antagonist | 0.086 0.005 DBMET01972 | DBMET01972 | |
| 0.014 | 0.751 | 0.212 | Tumour necrosis factor alpha release inhibitor | 0.212 0.099 DBMET01972 | DBMET01972 | |
| 0.045 | 0.812 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.148 DBMET01972 | DBMET01972 | |
| 0.002 | 0.795 | 0.047 | Prostaglandin EP3 antagonist | 0.047 0.011 DBMET01971 | DBMET01971 | |
| 0.017 | 0.81 | 0.105 | mTOR complex 1 inhibitor | 0.095 0.073 DBMET01965 0.105 0.052 DBMET01966 | DBMET01966 | |
| 0.005 | 0.799 | 0.178 | Anesthetic general | 0.178 0.088 DBMET01972 | DBMET01972 | |
| 0.01 | 0.814 | 0.28 | Cardiotonic | 0.193 0.126 DBMET01968 0.28 0.065 DBMET01969 0.28 0.065 DBMET01970 0.19 0.129 DBMET01971 | DBMET01970 | |
| 0.008 | 0.819 | 0.155 | Antiamyloidogenic | 0.155 0.141 DBMET01967 | DBMET01967 | |
| 0.016 | 0.834 | 0.755 | Nootropic | 0.755 0.005 DBMET01965 0.287 0.081 DBMET01966 | DBMET01965 | |
| 0.005 | 0.843 | 0.268 | Spasmolytic | 0.268 0.084 DBMET01971 | DBMET01971 | |
| 0.004 | 0.917 | 0.062 | Plasminogen activator inhibitor | 0.062 0.038 DBMET01969 0.062 0.038 DBMET01970 | DBMET01970 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |